It could be an important step forward in the improvement of pain therapy: Thanks to newly developed molecular probes, the behavior of individual opioid receptors can now be studied in detail.
Strong painkillers are very important in the management of patients with cancer and heart attack or requiring surgery. They extert their effect by binding to so-called opioid receptors in the body.
These painkillers have excellent efficacy, but also severe side effects. On the one hand, there is the danger of dependency, on the other hand, patients may become tolerant – i.e. the effectiveness of the drugs decreases with repeated use. This means that the dose must be increased over time to achieve the same effect.
Basic research on opioid receptors
Painkillers with less drastic undesirable effects and equally good efficacy would therefore be highly desirable. Michael Decker, Professor of Pharmaceutical and Medicinal Chemistry at Julius-Maximilians-Universität (JMU) Würzburg, in Bavaria, Germany, is pursuing research in this field. Among other things, his team wants to expand the basic knowledge about opioid receptors.
Decker now presents new findings in this field in the journal "Angewandte Chemie" together with Sébastien Granier from the Institut de Génomique Fonctionelle in Montpellier, Peter Gmeiner from the University of Erlangen-Nuremberg, and as main collaborator Professor Davide Calebiro from the University of Birmingham, UK. The JMU PhD students Christian Gentzsch, Kerstin Seier, and Antonios Drakopoulos were also involved in the work.
The receptors form short-lived pairs
The team dealt with a question that has been highly debated in the field so far. "It is still unclear whether the analgesic effect of opioids is mediated by individual receptors or whether it is necessary for the receptors to aggregate into pairs or larger molecular complexes," said Decker. Evidence has already been found for all these possibilities.
"Our results help reconciling some of the previously contradictory observations," says Davide Calebiro, who until recently was a researcher at JMU. "We found that most opioid receptors exist as individual entities in the cell membrane. However, a small proportion forms pairs of two. Although the lifespan of these pairs is short, they might contribute to the function of this important family of receptors."
Journal classifies work as "Highly Important“
This finding might be very important: "There is evidence that the receptor pairs have different pharmacological effects than individual receptors," said Decker. Therefore, it might be possible to develop new painkillers with a more favourable effect profile on the basis of this knowledge.
Due to the importance of these new findings, "Angewandte Chemie" has classified the publication of the JMU researchers as "highly important". It is freely available on the Web. In addition, the work was selected for one of the journal covers.
Highly selective ligands developed
The research team came to its conclusion because it had previously developed highly selective fluorescent ligands for a subtype of the receptors, the so-called mu opioid receptor (MOR). This is the most important of the three receptor subtypes and is responsible for the desired pain-relieving but also for the addictive effect. The new ligands can be used as molecular probes to label the receptor highly specifically and to observe its behaviour in living cells using single-molecule fluorescence microscopy.
The researchers are now working on the production of fluorescent ligands for the other two receptor subtypes (delta and kappa; DOR and KOR) in order to analyse their behaviour in the cell membrane as well. This has already been achieved with KOR (A. Drakopoulos et al., Journal of Medicinal Chemistry 2020, in print).
This work was financially supported by the Elite Network of Bavaria within the framework of the International PhD Program "Receptor Dynamics". Other sponsors were the Wellcome Trust, the German Research Foundation (DFG) and the National Institutes of Health (USA).
Prof. Dr. Michael Decker, Institute for Pharmacy and Food Chemistry, University of Würzburg, T +49 931 31-89676, firstname.lastname@example.org
Prof. Davide Calebiro, Institute of Metabolism and Systems Research, University of Birmingham, T +44 121 414 3928, email@example.com
Selective and Wash-Resistant Fluorescent Dihydrocodeinone Derivatives Allow Single-Molecule Imaging of mu-Opioid Receptor Dimerisation, Applied Chemistry, DOI 10.1002/ange.201912683, and Applied Chemistry International Edition, February 26, 2020, DOI 10.1002/anie.201912683
https://onlinelibrary.wiley.com/doi/full/10.1002/anie.201912683 Open Access publication in "Angewandte Chemie"
https://onlinelibrary.wiley.com/doi/full/10.1002/anie.202002281 Link to the cover of the magazine
https://pubs.acs.org/doi/10.1021/acs.jmedchem.9b02011 Publication in the Journal of Medicinal Chemistry, 11 March 2020
Robert Emmerich | Julius-Maximilians-Universität Würzburg
Biophysicists reveal how optogenetic tool works
29.05.2020 | Moscow Institute of Physics and Technology
Mapping immune cells in brain tumors
29.05.2020 | University of Zurich
In living cells, enzymes drive biochemical metabolic processes enabling reactions to take place efficiently. It is this very ability which allows them to be used as catalysts in biotechnology, for example to create chemical products such as pharmaceutics. Researchers now identified an enzyme that, when illuminated with blue light, becomes catalytically active and initiates a reaction that was previously unknown in enzymatics. The study was published in "Nature Communications".
Enzymes: they are the central drivers for biochemical metabolic processes in every living cell, enabling reactions to take place efficiently. It is this very...
Early detection of tumors is extremely important in treating cancer. A new technique developed by researchers at the University of California, Davis offers a significant advance in using magnetic resonance imaging to pick out even very small tumors from normal tissue. The work is published May 25 in the journal Nature Nanotechnology.
researchers at the University of California, Davis offers a significant advance in using magnetic resonance imaging to pick out even very small tumors from...
Microelectronics as a key technology enables numerous innovations in the field of intelligent medical technology. The Fraunhofer Institute for Biomedical Engineering IBMT coordinates the BMBF cooperative project "I-call" realizing the first electronic system for ultrasound-based, safe and interference-resistant data transmission between implants in the human body.
When microelectronic systems are used for medical applications, they have to meet high requirements in terms of biocompatibility, reliability, energy...
Thomas Heine, Professor of Theoretical Chemistry at TU Dresden, together with his team, first predicted a topological 2D polymer in 2019. Only one year later, an international team led by Italian researchers was able to synthesize these materials and experimentally prove their topological properties. For the renowned journal Nature Materials, this was the occasion to invite Thomas Heine to a News and Views article, which was published this week. Under the title "Making 2D Topological Polymers a reality" Prof. Heine describes how his theory became a reality.
Ultrathin materials are extremely interesting as building blocks for next generation nano electronic devices, as it is much easier to make circuits and other...
Scientists took a leukocyte as the blueprint and developed a microrobot that has the size, shape and moving capabilities of a white blood cell. Simulating a blood vessel in a laboratory setting, they succeeded in magnetically navigating the ball-shaped microroller through this dynamic and dense environment. The drug-delivery vehicle withstood the simulated blood flow, pushing the developments in targeted drug delivery a step further: inside the body, there is no better access route to all tissues and organs than the circulatory system. A robot that could actually travel through this finely woven web would revolutionize the minimally-invasive treatment of illnesses.
A team of scientists from the Max Planck Institute for Intelligent Systems (MPI-IS) in Stuttgart invented a tiny microrobot that resembles a white blood cell...
19.05.2020 | Event News
07.04.2020 | Event News
06.04.2020 | Event News
29.05.2020 | Materials Sciences
29.05.2020 | Materials Sciences
29.05.2020 | Power and Electrical Engineering